Evaluation of Intravenous immunoglobulin usage pattern in an educational hospital, a descriptive-cross sectional study, Bandar Abbas, IRAN

Message:
Article Type:
Research/Original Article (بدون رتبه معتبر)
Abstract:
Introduction
The goal of DUE is to improve patients’ care. Studying the administration and utilization pattern of IVIg is an important research topic due to its significant role in the treatment and control of many disorders, high prices, and limited availability. We aimed to evaluate the pattern of IVIg use in an educational hospital.
Material and methods
In this descriptive-cross sectional and retrospective study, 250 patients’ records included medical orders, nursing notes and drug chart were studied. We used FDA and UK protocol to evaluate of IVIg indications in our study. Data were analyzed using SPSS software.
Results
Prescription of IVIg in our hospital adhered to FDA- approved indications and red indications of UK guideline with 64.1% and 67.6%, respectively. ITP was the most common cause of the correct prescriptions (52.7% based on FDA guideline and 50% based on UK guideline). Sepsis (15.5%), hyperbillirubinemia (10.4%), encephalitis (3.5%), and aplastic anemia (1.38%) were incorrect indications of IVIg in our study. ADRs was observed in 14.5% of patients.
Discussions
Consumption of IVIg in our hospital, was more consistent with international guidelines compared with other hospitals in IRAN, of course unnecessary prescriptions cannot be ignored. We suggest to develop own national guideline and educate our prescribers to minimize irrational prescription of expensive and important medicines such as IVIg.
Language:
English
Published:
Trends in Pharmaceutical Sciences, Volume:5 Issue: 2, Jun 2019
Pages:
81 to 86
magiran.com/p2438912  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!